Yesterday, May 26, 2016, 107 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $0.02 to $20,083,643.73.

Highlighted Stocks Traded by Insiders:

Franklin Financial Network (FSB) - FREE Research Report

Allen Jimmy E., who is Director at Franklin Financial Network, sold 5,000 shares at $31.90 on May 26, 2016. Following this transaction, the Director owned 124,374 shares meaning that the stake was reduced by 3.86% with the 5,000-share transaction.

The shares most recently traded at $31.00, down $0.90, or 2.9% since the insider transaction. Historical insider transactions for Franklin Financial Network go as follows:

  • 4-Week # shares bought: 56,950
  • 4-Week # shares sold: 18,500
  • 12-Week # shares bought: 5,000
  • 12-Week # shares sold: 18,500
  • 24-Week # shares bought: 5,000
  • 24-Week # shares sold: 18,500

The average volume for Franklin Financial Network has been 44,000 shares per day over the past 30 days. Franklin Financial Network has a market cap of $339.7 million and is part of the financial sector and banking industry. Shares are down 0.8% year-to-date as of the close of trading on Thursday.

Franklin Financial Network, Inc. operates as the bank holding company for Franklin Synergy Bank, a chartered commercial bank that provides various banking and related financial services to small businesses, corporate entities, local governments, and individuals. The company has a P/E ratio of 17.0. Currently, there is 1 analyst who rates Franklin Financial Network a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on FSB - FREE

TheStreet Quant Ratings

rates Franklin Financial Network as a

buy

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, impressive record of earnings per share growth, compelling growth in net income, good cash flow from operations and solid stock price performance. We feel its strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. Get the full

Franklin Financial Network Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Female Health (FHCO) - FREE Research Report

Greco Michele, who is Exec. VP and CFO at Female Health, bought 4,000 shares at $1.28 on May 26, 2016. Following this transaction, the Exec. VP and CFO owned 67,845 shares meaning that the stake was boosted by 6.27% with the 4,000-share transaction.

The shares most recently traded at $1.36, up $0.08, or 5.98% since the insider transaction. Historical insider transactions for Female Health go as follows:

  • 4-Week # shares bought: 10,600
  • 4-Week # shares sold: 203,936
  • 12-Week # shares bought: 10,600
  • 12-Week # shares sold: 203,936
  • 24-Week # shares bought: 70,600
  • 24-Week # shares sold: 203,936

The average volume for Female Health has been 213,100 shares per day over the past 30 days. Female Health has a market cap of $38.3 million and is part of the consumer goods sector and consumer non-durables industry. Shares are down 6.9% year-to-date as of the close of trading on Thursday.

The Female Health Company develops, manufactures, and markets consumer health care products. It offers the FC2 female condom that provides women dual protection against unintended pregnancy and sexually transmitted infections, including HIV/AIDS. The stock currently has a dividend yield of 8.07%. The company has a P/E ratio of 14.3. Currently, there are no analysts who rate Female Health a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on FHCO - FREE

TheStreet Quant Ratings

rates Female Health as a

sell

. The company's weaknesses can be seen in multiple areas, such as its unimpressive growth in net income, disappointing return on equity and generally disappointing historical performance in the stock itself. Get the full

Female Health Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Northrim BanCorp (NRIM) - FREE Research Report

Wight David G, who is Director at Northrim BanCorp, bought 1,000 shares at $26.97 on May 26, 2016. Following this transaction, the Director owned 10,000 shares meaning that the stake was boosted by 11.11% with the 1,000-share transaction.

The shares most recently traded at $26.75, down $0.22, or 0.82% since the insider transaction. Historical insider transactions for Northrim BanCorp go as follows:

  • 4-Week # shares bought: 600
  • 4-Week # shares sold: 850
  • 12-Week # shares bought: 600
  • 12-Week # shares sold: 850
  • 24-Week # shares bought: 600
  • 24-Week # shares sold: 850

The average volume for Northrim BanCorp has been 16,800 shares per day over the past 30 days. Northrim BanCorp has a market cap of $188.0 million and is part of the financial sector and banking industry. Shares are up 0.19% year-to-date as of the close of trading on Thursday.

Northrim BanCorp, Inc. operates as bank holding company for Northrim Bank that provides commercial banking products and services to businesses and professional individuals primarily in Alaska. The company operates in two segments, Community Banking and Home Mortgage Lending. The stock currently has a dividend yield of 2.76%. The company has a P/E ratio of 10.9. Currently, there are no analysts who rate Northrim BanCorp a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on NRIM - FREE

TheStreet Quant Ratings

rates Northrim BanCorp as a

buy

. The company's strengths can be seen in multiple areas, such as its good cash flow from operations, solid stock price performance, attractive valuation levels and expanding profit margins. We feel its strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full

Northrim BanCorp Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.